VBIV is having an abnormal day in price and volumeBoth the price and the volume shows an Alpha characteristics. There is a potential.
−9.4211USD
−92.84 MUSD
8.68 MUSD
26.62 M
About VBI Vaccines, Inc.
Sector
Industry
CEO
Jeffrey R. Baxter
Website
Headquarters
Cambridge
Employees (FY)
138
Founded
1965
ISIN
CA91822J2020
FIGI
BBG000BB3S61
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Can VBIV jump again like earlier this month?VBIV popped 50 % to begin July and then promptly lost 75% and has been low volume and
sideways since. I have not been able to discern any catalyst for that action. Earnings show
an ongoing cash burn. In the past couple of days, the Price Volume Trend indicator has
detected a small increase in
$VBIV - Keeping an eye here at $2.69This is the floor it broke few days ago, making its way back up due to good news/FDA approval. Bounced around yesterday back here again after big sell off yesterday. Just an idea i've my eye on.
This may be their best batch yet....Looking ready for the buyout.... Best buy is bulding a run.... We hve a bullish formation with some significat top line breaks of a few strong resistance areas. We need a break through 3.60 ...clean and with follow through. This is a low volume stock so any increase in volume creates momentum quit
About to shoot up !!
This is purely a Technical Analysis. All My favourite moving averages are close to the price. There has been a nice coiling of moving averages which leads to a breakout. From Elliot Wave perspective it looks like a wave 4 appearing as a triangle. Expecting a Parabolic move as a wave 5. There is a p
WATCHING $VBIV for ENTRY TARGET @ 3.19WATCHING $VBIV for ENTRY TARGET @ 3.19
Look to the right. Entry target in grey. Sell target in green. Double position target in red. That’s it.
VBIV, Long BullishJust waiting on VOLUME
All other Technical Indicators are Bullish and ready to GO...
VBIV wave 3?If wave 1 was the smaller move earlier this year and with all the products in the pipeline I can't imagine anything other than that, this looks to be the trend.
VBIV BUY/LONG NOW READY! 3.30 to 9.60 by End 2022!TICKER CODE: VBIV
Company Name: VBI VACCINES, INC
US Stocks Health Technology Biotechnology
Position Proposed: BUY
FOMO BUY ENTRY: NOW READY (3.94)
NEXT BUY ENTRY: (3.30)
1st Partial Take Profit: 6.75(End 2021)
2nd Partial Take Profit: 9.60 (End 2022)
NOTE THAT THE TIMELINE IS ONLY AN ESTIMATION
VBIV long until Jul 26-Aug 23, with earnings @ Aug 4 ~$-0.07 EPSDISCLAIMER: I'm not a certified or licensed financial advisor, securities trader, or securities broker; and, this is not intended as financial or securities advice.
DISCLOSURE: I own shares of VBIV
Looking to the upper right at the 4-Day time period tracking pane, I measured out three most recent p
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VBIV is 0.6297 USD — it has increased by 3.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange VBI Vaccines, Inc. stocks are traded under the ticker VBIV.
VBI Vaccines, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
VBIV stock is 10.69% volatile and has beta coefficient of 2.49. Check out the list of the most volatile stocks — is VBI Vaccines, Inc. there?
One year price forecast for VBI Vaccines, Inc. has a max estimate of 5.0000 USD and a min estimate of 5.0000 USD.
VBIV earnings for the last quarter are −0.38 USD whereas the estimation was −0.14 USD which accounts for −171.43% surprise. Estimated earnings for the next quarter are −0.22 USD. See more details about VBI Vaccines, Inc. earnings.
VBI Vaccines, Inc. revenue for the last quarter amounts to 6.62 M USD despite the estimated figure of 13.25 M USD. In the next quarter revenue is expected to reach 5.36 M USD.
Yes, you can track VBI Vaccines, Inc. financials in yearly and quarterly reports right on TradingView.
VBIV stock has risen by 1.56% compared to the previous week, the month change is a 7.83% rise, over the last year VBI Vaccines, Inc. has showed a 80.44% decrease.
VBIV net income for the last quarter is −13.00 K USD, while the quarter before that showed −20.44 M USD of net income which accounts for 99.94% change. Track more VBI Vaccines, Inc. financial stats to get the full picture.
Today VBI Vaccines, Inc. has the market capitalization of 17.90 M, it has increased by 31.57% over the last week.
No, VBIV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VBIV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VBI Vaccines, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 138.00 employees. See our rating of the largest employees — is VBI Vaccines, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VBI Vaccines, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VBI Vaccines, Inc. stock shows the sell signal. See more of VBI Vaccines, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VBI Vaccines, Inc. future price: according to them, VBIV price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Read a more detailed VBI Vaccines, Inc. forecast: see what analysts think of VBI Vaccines, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VBI Vaccines, Inc. EBITDA is −52.67 M USD, and current EBITDA margin is −614.16%. See more stats in VBI Vaccines, Inc. financial statements.